SCHEMBL4439411

SCHEMBL4439411

O=C(O)Cc1ccc(C(F)(F)F)c(Cl)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.49
RXRA P19793 5/20 0.45
RXRB P28702 5/20 0.45
RXRG P48443 5/20 0.45
CLCN2 P51788 1/20 0.41
POLQ O75417 1/20 0.40
CXCL8 P10145 4/20 0.39
CAMK2A Q9UQM7 1/20 0.38
AKR1B10 O60218 1/20 0.37
UGT1A9 O60656 1/20 0.37
TRPA1 O75762 1/20 0.37
ABCB11 O95342 1/20 0.37
MT-CO2 P00403 1/20 0.37
TTR P02766 1/20 0.37
ALB P02768 1/20 0.37
UGT1A6 P19224 1/20 0.37
UGT1A1 P22309 1/20 0.37
PTGS1 P23219 1/20 0.37
CXCR1 P25024 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29009948 0.85 RXRA (0.44) PTGS2RXRARXRBRXRGCLCN2
SCHEMBL30427864 0.85 RXRA (0.44) PTGS2RXRARXRBRXRGCLCN2
SCHEMBL6605072 0.84 PTGS2 (0.58) PTGS2RXRAP2RX7
SCHEMBL29718508 0.84 PTGS2 (0.58) PTGS2RXRAP2RX7
SCHEMBL722336 0.77 POLQ (0.62) PTGS2RXRARXRBRXRGPOLQ
SCHEMBL671103 0.77 POLQ (0.48) PTGS2RXRARXRBRXRGPOLQ
SCHEMBL18302050 0.77 AKR1B1 (0.47) PTGS2RXRARXRBRXRGCLCN2
SCHEMBL18301971 0.77 AKR1B1 (0.52) PTGS2RXRARXRBRXRGCLCN2
SCHEMBL4900831 0.77 CXCL8 (0.50) PTGS2CLCN2CXCL8CAMK2AAKR1B10
SCHEMBL3648899 0.76 RXRA (0.46) PTGS2RXRARXRBRXRGPOLQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125753-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed
WO-2008082003-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-10 WO disclosed